Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization.

Chronic myeloid leukemia (CML) is thought to arise from a pluripotent hematopoietic stem cell that has undergone a reciprocal translocation between the BCR gene on chromosome 22 and the ABL proto-oncogene on chromosome 9. This rearrangement results in a shortened chromosome 22, designated the Philadelphia (Ph) chromosome. The Ph chromosome has been found in cells from all hematopoietic lineages except mature T lymphocytes. To examine this issue, we combined fluorescence-activated cell sorting (FACS) and fluorescence in situ hybridization (FISH) to study lineage involvement of mature cells and stem cells in 12 patients with CML in the chronic phase. We found Ph chromosomes in myeloid cells and most B lymphocytes (CD19(+)) but not in mature T cells (CD3(+)) or natural killer (NK) cells (CD3(-)56(+)). Moreover, evidence of BCR/ABL fusion was found in pluripotent stem cells (CD34(+)Thy-1(+)), B-progenitor cells (CD34(+)CD19(+)), T/NK progenitor cells (CD34(+)CD7(+) cells), and T progenitor cells (CD34(+)CD7(+)CD5(+)) with a frequency equal to that in all CD34(+) cells isolated by FACS from bone marrow cells. T lymphocytes showed a marked decrease in Ph+ cells between progenitor cells and mature cells. Moreover, the ratios of Ph+ to Ph- cells in mature T cells and NK cells were below background levels, whereas Ph+ B lymphocytes also decreased during their maturation. These data suggest that Ph+ lymphocytes are eliminated during differentiation. In contrast to FISH of blood and bone marrow, which gives information principally about mature cells, the technique of "sorter FISH (FACS + FISH)" provides a powerful tool to explore the cytogenetic changes in immature cell populations of stem cell diseases based on immunophenotypes. Further clarification of genetic changes in stem cells could be achieved by using sorter FISH with monoclonal antibodies.

[1]  L. Lanier,et al.  Development of human T and natural killer cells. , 1995, Blood.

[2]  H. Gralnick,et al.  Characteristics of blast crisis in chronic granulocytic leukemia. , 1977, Blood.

[3]  D. Rosenthal,et al.  Differentiation patterns in the blastic phase of chronic myeloid leukemia. , 1983, Blood.

[4]  D Pinkel,et al.  Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization , 1990, Science.

[5]  F. Lemoine,et al.  Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. , 1993, Blood.

[6]  P. Lansdorp,et al.  Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.

[7]  V. Najfeld,et al.  Evidence for a multistep pathogenesis of chronic myelogenous leukemia. , 1981, Blood.

[8]  J. Miller,et al.  Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. , 1994, Blood.

[9]  N. Kamada,et al.  Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. , 1978 .

[10]  S. Jhanwar,et al.  Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. , 1985, Blood.

[11]  R. Barr,et al.  Preliminary evidence for the common origin of a lympho-myeloid complex in man. , 1978, Acta haematologica.

[12]  A. Denman,et al.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. , 1978, The Journal of clinical investigation.

[13]  M. Sasaki,et al.  Lymphocyte Lifetime in Women , 1965, Science.

[14]  B. Zehnbauer,et al.  BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. , 1993, Blood.

[15]  M. Walter,et al.  Early T cell differentiated chronic myeloid leukemia blast crisis with rearrangement of the breakpoint cluster region but not of the T cell receptor beta chain genes. , 1987, Blood.

[16]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.

[17]  C. Verfaillie,et al.  The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture. , 1992, Blood.

[18]  Williams Ln.  Semi-security and psychiatric hospitals. , 1974 .

[19]  M. Marani,et al.  Ph1-negative T lymphocytic colonies in agar cultures of peripheral blood in chronic myeloid leukemia. , 1981, Acta haematologica.

[20]  K. Franssila,et al.  Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms , 1994, Genes, chromosomes & cancer.

[21]  J. Phillips,et al.  Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloid-cell development , 1993 .

[22]  E. Canaani,et al.  Molecular biology of chronic myelogenous leukemia. , 1988, Seminars in hematology.

[23]  S. Lawler.  The cytogenetics of chronic granulocytic leukaemia. , 1977, Clinics in haematology.

[24]  E. Lotzová,et al.  Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors. , 1993, Journal of immunology.

[25]  N. Kamada,et al.  Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. , 1978, Blood.

[26]  Lawler Sd.  The cytogenetics of chronic granulocytic leukaemia. , 1977 .

[27]  M. Caligiuri,et al.  Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. , 1996, Blood.

[28]  P. Smith,et al.  Lymphocyte Survival in Men treated with X-rays for Ankylosing Spondylitis , 1967, Nature.

[29]  R. Brunning,et al.  Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. , 1994, Leukemia.

[30]  Torsten Haferlach,et al.  Which compartments are involved in Philadelphia‐chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques , 1997, British journal of haematology.

[31]  H. Juneja,et al.  Presence of the Philadelphia chromosome (Ph1) in pokeweed mitogen stimulated lymphocytes during chronic phase of chronic myelocytic leukemia (CML). , 1981, Cancer genetics and cytogenetics.

[32]  M. Greaves,et al.  Clonal rearrangement and expression of the T cell receptor beta gene and involvement of the breakpoint cluster region in blast crisis of CGL. , 1986, Blood.

[33]  L. Kearney,et al.  T-CELL CYTOGENETICS IN CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.

[34]  J U Gutterman,et al.  The molecular genetics of Philadelphia chromosome-positive leukemias. , 1988, The New England journal of medicine.

[35]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.